AAPL329.89-3.19 (-0.96%) ▼|ABBV262.61+0.84 (+0.32%) ▲|ABT101.85-1.24 (-1.20%) ▼|ACN196.97+1.97 (+1.01%) ▲|ADBE263.14-2.46 (-0.93%) ▼|AMAT418.01-6.21 (-1.46%) ▼|AMD503.78+10.37 (+2.10%) ▲|AMGN378.07-3.43 (-0.90%) ▼|AMT177.02+0.08 (+0.05%) ▲|AMZN248.57-4.97 (-1.96%) ▼|AVGO338.56-6.16 (-1.79%) ▼|AXP324.25-3.53 (-1.08%) ▼|BA210.81+0.54 (+0.25%) ▲|BAC59.53+0.06 (+0.09%) ▲|BKNG171.48-3.87 (-2.21%) ▼|BLK1,054.53-11.07 (-1.04%) ▼|BMY63.77-0.33 (-0.51%) ▼|BNY155.08-2.58 (-1.64%) ▼|BRK-B514.82-0.13 (-0.03%) ▼|C135.48-0.71 (-0.52%) ▼|CAT784.42+0.42 (+0.05%) ▲|CL87.27-0.62 (-0.71%) ▼|CMCSA24.64-0.25 (-0.98%) ▼|COF206.21-0.47 (-0.23%) ▼|COP141.42+4.75 (+3.47%) ▲|COST908.25-10.66 (-1.16%) ▼|CRM259.90+0.47 (+0.18%) ▲|CSCO109.96-0.11 (-0.10%) ▼|CVS94.68-0.87 (-0.91%) ▼|CVX216.90+4.73 (+2.23%) ▲|DE688.12+6.66 (+0.98%) ▲|DHR207.33+4.08 (+2.01%) ▲|DIS107.39-1.20 (-1.11%) ▼|DUK118.11-0.91 (-0.76%) ▼|EMR146.92-1.38 (-0.93%) ▼|FDX309.38-3.19 (-1.02%) ▼|GD357.96+1.15 (+0.32%) ▲|GE309.33-8.23 (-2.59%) ▼|GEV879.12+4.36 (+0.50%) ▲|GILD145.45-0.14 (-0.10%) ▼|GM85.64-1.52 (-1.74%) ▼|GOOG339.69-6.02 (-1.74%) ▼|GOOGL343.19-6.20 (-1.77%) ▼|GS960.68-27.77 (-2.81%) ▼|HD307.53-3.34 (-1.07%) ▼|HON200.72-0.66 (-0.33%) ▼|IBM250.64+1.55 (+0.62%) ▲|INTC97.67+0.48 (+0.49%) ▲|INTU337.51-1.64 (-0.48%) ▼|ISRG376.82-1.12 (-0.30%) ▼|JNJ264.65-1.68 (-0.63%) ▼|JPM345.28-4.85 (-1.39%) ▼|KO88.45-0.38 (-0.42%) ▼|LIN462.65-1.76 (-0.38%) ▼|LLY1,141.46+3.18 (+0.28%) ▲|LMT533.64+4.26 (+0.80%) ▲|LOW195.46-2.71 (-1.37%) ▼|LRCX267.16-6.33 (-2.31%) ▼|MA571.70-2.72 (-0.47%) ▼|MCD254.19-3.30 (-1.28%) ▼|MDLZ62.15-0.25 (-0.39%) ▼|MDT94.03+0.23 (+0.25%) ▲|META666.36+0.76 (+0.11%) ▲|MMM164.31+2.29 (+1.41%) ▲|MO70.13+0.63 (+0.90%) ▲|MRK143.63-0.37 (-0.26%) ▼|MS202.75-3.84 (-1.86%) ▼|MSFT499.41-6.00 (-1.19%) ▼|MU924.85+0.82 (+0.09%) ▲|NEE81.61-0.03 (-0.03%) ▼|NFLX78.33-1.99 (-2.48%) ▼|NKE36.43-0.62 (-1.67%) ▼|NOW145.11+2.76 (+1.94%) ▲|NVDA211.67+0.71 (+0.34%) ▲|ORCL143.08-1.71 (-1.18%) ▼|PEP135.46-0.88 (-0.65%) ▼|PFE27.49-0.24 (-0.85%) ▼|PG147.08+0.95 (+0.65%) ▲|PLTR176.17+2.86 (+1.65%) ▲|PM193.19-1.68 (-0.86%) ▼|QCOM188.57+8.42 (+4.67%) ▲|RTX195.71+0.37 (+0.19%) ▲|SBUX96.62-2.46 (-2.48%) ▼|SCHW108.19+0.88 (+0.82%) ▲|SO86.29-0.71 (-0.82%) ▼|SPG203.98-0.99 (-0.48%) ▼|T26.82+0.31 (+1.17%) ▲|TMO636.22+23.07 (+3.76%) ▲|TMUS181.40-1.50 (-0.82%) ▼|TSLA357.10-1.88 (-0.52%) ▼|TXN263.61+0.19 (+0.07%) ▲|UBER71.93-0.70 (-0.96%) ▼|UNH376.31-7.24 (-1.89%) ▼|UNP284.83-0.25 (-0.09%) ▼|UPS102.58+0.12 (+0.12%) ▲|USB62.28-0.40 (-0.64%) ▼|V374.81-0.47 (-0.13%) ▼|VZ51.57+0.28 (+0.55%) ▲|WFC89.07+0.36 (+0.41%) ▲|WMT108.70-0.38 (-0.35%) ▼|XOM169.31+4.23 (+2.56%) ▲|AAPL329.89-3.19 (-0.96%) ▼|ABBV262.61+0.84 (+0.32%) ▲|ABT101.85-1.24 (-1.20%) ▼|ACN196.97+1.97 (+1.01%) ▲|ADBE263.14-2.46 (-0.93%) ▼|AMAT418.01-6.21 (-1.46%) ▼|AMD503.78+10.37 (+2.10%) ▲|AMGN378.07-3.43 (-0.90%) ▼|AMT177.02+0.08 (+0.05%) ▲|AMZN248.57-4.97 (-1.96%) ▼|AVGO338.56-6.16 (-1.79%) ▼|AXP324.25-3.53 (-1.08%) ▼|BA210.81+0.54 (+0.25%) ▲|BAC59.53+0.06 (+0.09%) ▲|BKNG171.48-3.87 (-2.21%) ▼|BLK1,054.53-11.07 (-1.04%) ▼|BMY63.77-0.33 (-0.51%) ▼|BNY155.08-2.58 (-1.64%) ▼|BRK-B514.82-0.13 (-0.03%) ▼|C135.48-0.71 (-0.52%) ▼|CAT784.42+0.42 (+0.05%) ▲|CL87.27-0.62 (-0.71%) ▼|CMCSA24.64-0.25 (-0.98%) ▼|COF206.21-0.47 (-0.23%) ▼|COP141.42+4.75 (+3.47%) ▲|COST908.25-10.66 (-1.16%) ▼|CRM259.90+0.47 (+0.18%) ▲|CSCO109.96-0.11 (-0.10%) ▼|CVS94.68-0.87 (-0.91%) ▼|CVX216.90+4.73 (+2.23%) ▲|DE688.12+6.66 (+0.98%) ▲|DHR207.33+4.08 (+2.01%) ▲|DIS107.39-1.20 (-1.11%) ▼|DUK118.11-0.91 (-0.76%) ▼|EMR146.92-1.38 (-0.93%) ▼|FDX309.38-3.19 (-1.02%) ▼|GD357.96+1.15 (+0.32%) ▲|GE309.33-8.23 (-2.59%) ▼|GEV879.12+4.36 (+0.50%) ▲|GILD145.45-0.14 (-0.10%) ▼|GM85.64-1.52 (-1.74%) ▼|GOOG339.69-6.02 (-1.74%) ▼|GOOGL343.19-6.20 (-1.77%) ▼|GS960.68-27.77 (-2.81%) ▼|HD307.53-3.34 (-1.07%) ▼|HON200.72-0.66 (-0.33%) ▼|IBM250.64+1.55 (+0.62%) ▲|INTC97.67+0.48 (+0.49%) ▲|INTU337.51-1.64 (-0.48%) ▼|ISRG376.82-1.12 (-0.30%) ▼|JNJ264.65-1.68 (-0.63%) ▼|JPM345.28-4.85 (-1.39%) ▼|KO88.45-0.38 (-0.42%) ▼|LIN462.65-1.76 (-0.38%) ▼|LLY1,141.46+3.18 (+0.28%) ▲|LMT533.64+4.26 (+0.80%) ▲|LOW195.46-2.71 (-1.37%) ▼|LRCX267.16-6.33 (-2.31%) ▼|MA571.70-2.72 (-0.47%) ▼|MCD254.19-3.30 (-1.28%) ▼|MDLZ62.15-0.25 (-0.39%) ▼|MDT94.03+0.23 (+0.25%) ▲|META666.36+0.76 (+0.11%) ▲|MMM164.31+2.29 (+1.41%) ▲|MO70.13+0.63 (+0.90%) ▲|MRK143.63-0.37 (-0.26%) ▼|MS202.75-3.84 (-1.86%) ▼|MSFT499.41-6.00 (-1.19%) ▼|MU924.85+0.82 (+0.09%) ▲|NEE81.61-0.03 (-0.03%) ▼|NFLX78.33-1.99 (-2.48%) ▼|NKE36.43-0.62 (-1.67%) ▼|NOW145.11+2.76 (+1.94%) ▲|NVDA211.67+0.71 (+0.34%) ▲|ORCL143.08-1.71 (-1.18%) ▼|PEP135.46-0.88 (-0.65%) ▼|PFE27.49-0.24 (-0.85%) ▼|PG147.08+0.95 (+0.65%) ▲|PLTR176.17+2.86 (+1.65%) ▲|PM193.19-1.68 (-0.86%) ▼|QCOM188.57+8.42 (+4.67%) ▲|RTX195.71+0.37 (+0.19%) ▲|SBUX96.62-2.46 (-2.48%) ▼|SCHW108.19+0.88 (+0.82%) ▲|SO86.29-0.71 (-0.82%) ▼|SPG203.98-0.99 (-0.48%) ▼|T26.82+0.31 (+1.17%) ▲|TMO636.22+23.07 (+3.76%) ▲|TMUS181.40-1.50 (-0.82%) ▼|TSLA357.10-1.88 (-0.52%) ▼|TXN263.61+0.19 (+0.07%) ▲|UBER71.93-0.70 (-0.96%) ▼|UNH376.31-7.24 (-1.89%) ▼|UNP284.83-0.25 (-0.09%) ▼|UPS102.58+0.12 (+0.12%) ▲|USB62.28-0.40 (-0.64%) ▼|V374.81-0.47 (-0.13%) ▼|VZ51.57+0.28 (+0.55%) ▲|WFC89.07+0.36 (+0.41%) ▲|WMT108.70-0.38 (-0.35%) ▼|XOM169.31+4.23 (+2.56%) ▲|
22.6 C
New York
Tuesday, September 15, 2026

Tag: progress

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development

MINNEAPOLIS, June 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company...

Abitibi Metals Expands Mid-Level High-Grade Copper Zones at B26: 4.8% CuEq Over 4.1m within 63.2m at 1% CuEq

Highlights: Results from targeted drilling which expanded high-grade areas of the B26 Deposit: Hole 1274-25-363 – 1% CuEq over 63.2 metres beginning at 412.3 metres depth,...

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

Orally administered treatment was well tolerated, with early signs of clinical activityIn models of non-proliferative diabetic retinopathy (NPDR), danegaptide has demonstrated protection against retinal...

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

Orally administered treatment was well tolerated, with early signs of clinical activityIn models of non-proliferative diabetic retinopathy (NPDR), danegaptide has demonstrated protection against retinal...

EMR June 2025 highlights growing monetization appeal of 5G fixed wireless access

More than half of all service providers globally who offer fixed wireless access now do so with speed-based monetization benefits enhanced by 5G5G subscriptions...

Aalberts reports the progress of its share buyback programme 16 June – 20 June 2025

Aalberts today reports that it has repurchased 99,111 of its own shares in the period from 16 June 2025, up to and including 20 June 2025, for an amount of EUR 2,939,682.20, so at an average share price of EUR 29.66.

Bragar Eagel & Squire, P.C. Is Investigating Arvinas, Semler, and Abacus and Encourages Investors to Contact the Firm

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Arvinas, Inc. (NASDAQ:ARVN), Semler Scientific Inc. (NASDAQ:SMLR), and Abacus Global Management, Inc. (NASDAQ:ABL). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Reckitt Benckiser Group plc (OTC:RBGLY), UroGen Pharma Ltd. (NASDAQ:URGN), Red Cat Holdings, Inc. (NASDAQ: RCAT) and Fortrea Holdings Inc. (NASDAQ:FTRE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Fortrea Holdings Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Fraud Class Action Pending Against FTRE

Robbins LLP is Investigating Allegations that Fortrea Holdings, Inc. (FTRE) Misled Investors Regarding the Progress of its Pre-Spin Projects

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership...

PALO ALTO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its Board of Directors (the “Board”) has approved a deferral of the previously announced record date of May 2, 2025 for the Company’s previously announced dividend of Scilex preferred stock (the “Dividend”) to its stockholders and certain other securityholders of Scilex. The new record date for the Dividend will be such later date to be determined in the sole discretion of the Board (such later record date as so determined by the Board, the “New Record Date”). The Board retains the right to continue to change any New Record Date (and therefore any related payment date for the Dividend) and the ability to revoke the Dividend.

DTE Energy Board of Directors elects Joi Harris as CEO; Jerry Norcia elected Executive Board Chairman

Harris's 34-year track record of proven leadership at DTE and strong working relationship with Norcia to ensure a smooth, successful transition DETROIT, June 23, 2025...

Ekinops completes the CELTIC-Next connectivity initiative EMBRACE

PARIS, June 23, 2025 /PRNewswire/ -- EKINOPS (Euronext Paris - FR0011466069 – EKI), a leading supplier of optical transport and enterprise-trusted connectivity solutions, today announces the...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsProgress